Display options
Cite
Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015;7:595-603doi: 10.2147/IJWH.S78829.
Muñoz-Hernando, L., Muñoz-Gonzalez, J. L., Marqueta-Marques, L., Alvarez-Conejo, C., Tejerizo-García, �. �., Lopez-Gonzalez, G., Villegas-Muñoz, E., Martin-Jimenez, A., & Jiménez-López, J. S. (2015). Endometriosis: alternative methods of medical treatment. International journal of women's health, 7595-603. https://doi.org/10.2147/IJWH.S78829
Muñoz-Hernando, Leticia, et al. "Endometriosis: alternative methods of medical treatment." International journal of women's health vol. 7 (2015): 595-603. doi: https://doi.org/10.2147/IJWH.S78829
Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-García Á, Lopez-Gonzalez G, Villegas-Muñoz E, Martin-Jimenez A, Jiménez-López JS. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015 Jun 11;7:595-603. doi: 10.2147/IJWH.S78829. eCollection 2015. PMID: 26089705; PMCID: PMC4468987.
Copy Download .nbib Format: NLM
Share it on

Int J Womens Health. 2015 Jun 11;7:595-603. doi: 10.2147/IJWH.S78829. eCollection 2015.

Endometriosis: alternative methods of medical treatment.

International journal of women's health

Leticia Muñoz-Hernando, Jose L Muñoz-Gonzalez, Laura Marqueta-Marques, Carmen Alvarez-Conejo, Álvaro Tejerizo-García, Gregorio Lopez-Gonzalez, Emilia Villegas-Muñoz, Angel Martin-Jimenez, Jesús S Jiménez-López

Affiliations

  1. Endometriosis Unit, Service of Obstetrics and Gynecology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  2. Endometriosis Unit, Service of Obstetrics and Gynecology, Hospital Carlos Haya, Malaga, Spain.
  3. Endometriosis Unit, Service of Obstetrics and Gynecology, Hospital Son Llatzer, Palma de Mallorca, Spain.

PMID: 26089705 PMCID: PMC4468987 DOI: 10.2147/IJWH.S78829

Abstract

Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at extrauterine sites. The main purpose of endometriosis management is alleviating pain associated to the disease. This can be achieved surgically or medically, although in most women a combination of both treatments is required. Long-term medical treatment is usually needed in most women. Unfortunately, in most cases, pain symptoms recur between 6 months and 12 months once treatment is stopped. The authors conducted a literature search for English original articles, related to new medical treatments of endometriosis in humans, including articles published in PubMed, Medline, and the Cochrane Library. Keywords included "endometriosis" matched with "medical treatment", "new treatment", "GnRH antagonists", "Aromatase inhibitors", "selective progesterone receptor modulators", "anti-TNF α", and "anti-angiogenic factors". Hormonal treatments currently available are effective in the relief of pain associated to endometriosis. Among new hormonal drugs, association to aromatase inhibitors could be effective in the treatment of women who do not respond to conventional therapies. GnRH antagonists are expected to be as effective as GnRH agonists, but with easier administration (oral). There is a need to find effective treatments that do not block the ovarian function. For this purpose, antiangiogenic factors could be important components of endometriosis therapy in the future. Upcoming researches and controlled clinical trials should focus on these drugs.

Keywords: GnRH antagonists; anti-TNF-α; antiangiogenic factors; aromatase inhibitors; endometrial tissue; hormonal treatments; pharmacological treatment options; selective progesterone receptor modulators

References

  1. Hum Reprod. 2013 Jun;28(6):1552-68 - PubMed
  2. Fertil Steril. 2004 Feb;81(2):290-6 - PubMed
  3. Am J Pathol. 2002 Sep;161(3):909-18 - PubMed
  4. Gynecol Obstet Invest. 2010;69(2):93-100 - PubMed
  5. Fertil Steril. 1993 Jul;60(1):75-9 - PubMed
  6. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001019 - PubMed
  7. Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):245-63 - PubMed
  8. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008088 - PubMed
  9. Reprod Sci. 2014 Mar;21(3):363-71 - PubMed
  10. Angiogenesis. 2005;8(2):147-56 - PubMed
  11. Fertil Steril. 2005 Mar;83(3):793-5 - PubMed
  12. Hum Reprod. 2008 Sep;23(9):2017-23 - PubMed
  13. J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):54-8 - PubMed
  14. Reproduction. 2013 Jan 24;145(2):119-26 - PubMed
  15. Expert Opin Pharmacother. 2010 Feb;11(3):481-8 - PubMed
  16. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000068 - PubMed
  17. Cancer Biol Ther. 2006 Jan;5(1):22-7 - PubMed
  18. J Clin Endocrinol Metab. 1996 Mar;81(3):1118-22 - PubMed
  19. Lancet. 2001 Nov 24;358(9295):1793-803 - PubMed
  20. Endocr Rev. 1994 Jun;15(3):342-55 - PubMed
  21. Hum Reprod. 2007 May;22(5):1474-80 - PubMed
  22. Am J Obstet Gynecol. 1998 Jun;178(6):1151-6 - PubMed
  23. Fertil Steril. 2010 Mar 1;93(4):1316-23 - PubMed
  24. Fertil Steril. 2005 Oct;84 Suppl 2:1144-55 - PubMed
  25. Hum Reprod. 2009 Sep;24(9):2133-41 - PubMed
  26. Hum Reprod. 1997 Sep;12(9):2046-50 - PubMed
  27. Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):319-28 - PubMed
  28. Hum Reprod. 2001 Mar;16(3):561-6 - PubMed
  29. Fertil Steril. 2005 Aug;84(2):300-4 - PubMed
  30. Cochrane Database Syst Rev. 2010 Dec 08;(12):CD008475 - PubMed
  31. Hum Reprod. 2008 Aug;23(8):1910-6 - PubMed
  32. J Clin Endocrinol Metab. 1997 May;82(5):1621-8 - PubMed
  33. N Engl J Med. 2010 Jun 24;362(25):2389-98 - PubMed
  34. Expert Opin Pharmacother. 2013 Feb;14(3):291-305 - PubMed
  35. Expert Opin Drug Saf. 2005 May;4(3):491-9 - PubMed
  36. J Clin Endocrinol Metab. 2003 Jun;88(6):2889-99 - PubMed
  37. Fertil Steril. 2005 Oct;84(4):1033-6 - PubMed
  38. Mol Hum Reprod. 2006 Jul;12(7):421-6 - PubMed
  39. Hum Reprod. 2014 Mar;29(3):400-12 - PubMed
  40. Fertil Steril. 2010 May 1;93(7):2150-61 - PubMed
  41. J Clin Endocrinol Metab. 2009 Jul;94(7):2489-94 - PubMed
  42. J Clin Endocrinol Metab. 2004 Mar;89(3):1089-95 - PubMed
  43. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004753 - PubMed
  44. Contraception. 2010 Jan;81(1):1-7 - PubMed
  45. J Minim Invasive Gynecol. 2008 Jan-Feb;15(1):62-6 - PubMed
  46. Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):222-5 - PubMed
  47. Hum Reprod Update. 2007 Jul-Aug;13(4):331-42 - PubMed
  48. Hum Reprod. 2004 Jan;19(1):160-7 - PubMed
  49. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD002122 - PubMed
  50. Fertil Steril. 1996 Jan;65(1):23-8 - PubMed
  51. Hum Reprod. 2009 Dec;24(12):3033-41 - PubMed
  52. Eur J Obstet Gynecol Reprod Biol. 2004 Sep 10;116(1):100-2 - PubMed
  53. Fertil Steril. 2011 Aug;96(2):428-33 - PubMed
  54. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD005072 - PubMed
  55. Cochrane Database Syst Rev. 2012 Jan 18;1:CD007677 - PubMed
  56. Br J Cancer. 2007 Jun 18;96(12 ):1788-95 - PubMed
  57. N Engl J Med. 2012 Feb 2;366(5):409-20 - PubMed
  58. Ann N Y Acad Sci. 2002 Mar;955:373-88; discussion 389-93, 396-406 - PubMed
  59. Fertil Steril. 2010 May 15;93(8):2674-9 - PubMed
  60. Arch Gynecol Obstet. 2011 Jul;284(1):105-10 - PubMed
  61. Expert Opin Investig Drugs. 2011 Jul;20(7):917-31 - PubMed
  62. J Clin Endocrinol Metab. 1996 Mar;81(3):1273-7 - PubMed
  63. Hum Reprod Update. 2012 Nov-Dec;18(6):682-702 - PubMed
  64. Fertil Steril. 2007 Sep;88(3):724-6 - PubMed
  65. N Engl J Med. 2009 Jan 15;360(3):268-79 - PubMed
  66. Curr Cancer Drug Targets. 2005 Dec;5(8):579-94 - PubMed
  67. Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):199-202 - PubMed
  68. N Engl J Med. 2012 Feb 2;366(5):421-32 - PubMed
  69. Reprod Sci. 2011 Jul;18(7):614-22 - PubMed
  70. Cancer Chemother Pharmacol. 2011 Aug;68(2):293-300 - PubMed
  71. Nat Med. 2004 Mar;10 (3):255-61 - PubMed

Publication Types